Hepabig 100 IU Injection is a human hepatitis B immunoglobulin (HBIG) preparation used to provide temporary, passive protection against hepatitis B virus (HBV) following certain types of exposure. It contains ready-made antibodies that can help protect against HBV while the body's own immune response develops. Hepatitis B immunoglobulin is generally used for post-exposure prophylaxis and, in specific clinical situations, alongside hepatitis B vaccination.
What Is Hepabig 100 IU Injection?
Hepabig 100 IU Injection contains human hepatitis B immunoglobulin, which supplies anti-HBs antibodies to the body. Unlike the hepatitis B vaccine, which stimulates the immune system to develop its own protection, HBIG provides passive immunity that works immediately but is temporary.
HBIG may be considered after exposure to HBV through infected blood or body fluids, including certain occupational or accidental exposures. It can also be used in specific situations involving newborns of mothers with hepatitis B and other high-risk clinical circumstances, according to applicable medical guidelines.
Uses of Hepabig 100 IU Injection
The main Hepabig 100 IU Injection uses are associated with prevention of hepatitis B infection after exposure.
1. Post-Exposure Prophylaxis
HBIG can be administered after exposure to HBV-positive blood or potentially infectious body fluids. Examples can include accidental needlestick injuries, certain mucosal exposures, and other documented occupational or non-occupational exposures. When indicated, post-exposure prophylaxis should be started as soon as possible.
2. Prevention of Mother-to-Child Transmission
HBIG may be administered to newborns born to mothers who are infected with hepatitis B, together with hepatitis B vaccination according to applicable guidelines. This combined approach helps provide immediate passive protection while active immunity develops from vaccination.
3. Selected High-Risk Clinical Situations
HBIG may also have a role in selected patients undergoing liver transplantation or other situations where preventing HBV reinfection is clinically important. Its use and dosing depend on the patient's medical circumstances and the protocol followed by the treating specialist.
Benefits of Hepabig 100 IU Injection
One important benefit of Hepabig is that it provides passive immunity by supplying ready-made antibodies against hepatitis B.
Key benefits include:
- Provides temporary protection against HBV after certain exposures.
- Can be used as part of post-exposure prophylaxis when clinically indicated.
- May be combined with hepatitis B vaccination in appropriate patients.
- Provides antibodies without requiring the body to first develop its own immune response.
- Has an established role in selected hepatitis B prevention protocols.
HBIG protection is temporary, generally lasting around 3–6 months, so it should not be considered a replacement for hepatitis B vaccination when vaccination is indicated.
Hepabig 100 IU Injection Dosage
The Hepabig 100 IU Injection dosage should always be determined by a qualified healthcare professional according to the type of exposure, age, body weight, vaccination history, and applicable clinical guidelines.
For many adult post-exposure situations, CDC guidance specifies a standard HBIG dose of 0.06 mL/kg administered intramuscularly (IM). HBIG may be administered at the same time as hepatitis B vaccine, but at a different injection site.
The appropriate dose for newborns and other specific clinical situations can differ. Therefore, patients and caregivers should not calculate or administer the dose themselves.
Precautions and Safety Information
Before receiving Hepabig 100 IU Injection, tell the healthcare professional about any previous reactions to human immunoglobulin products or other relevant medical conditions.
Possible reactions can include injection-site pain or tenderness, urticaria, or other allergic reactions. Serious hypersensitivity reactions such as anaphylaxis are uncommon but have been reported with human immunoglobulin preparations.
Hepabig should be administered by an appropriately trained healthcare professional. It should not be self-injected unless specifically instructed and supervised according to the applicable product information.
Storage of Hepabig 100 IU Injection
Hepabig 100 IU Injection should be stored under the temperature conditions specified by the product manufacturer. Available product information indicates refrigerated storage at 2°C–8°C and advises not to freeze the product.
Proper cold-chain handling is particularly important when the product is transported or supplied internationally.
Frequently Asked Questions
Is Hepabig 100 IU Injection a vaccine?
No. Hepabig is a hepatitis B immunoglobulin product that provides passive immunity. The hepatitis B vaccine stimulates the body to develop active immunity. HBIG is often used alongside vaccination when post-exposure prophylaxis is indicated.
How quickly should HBIG be given after exposure?
When HBIG is indicated, it should generally be administered as soon as possible after exposure. The appropriate timing depends on the exposure and patient circumstances.
Can Hepabig prevent hepatitis B after a needlestick injury?
HBIG can be part of post-exposure prophylaxis following certain needlestick and blood exposures, particularly when the source is known to be HBsAg-positive and the exposed person's vaccination status indicates HBIG is needed.
How should Hepabig be stored?
It should generally be refrigerated at 2°C–8°C and must not be frozen, subject to the specific manufacturer's product information.
Conclusion
Hepabig 100 IU Injection is a human hepatitis B immunoglobulin used to provide temporary passive protection against hepatitis B following specific exposure risks and in selected clinical situations. Its uses, dosage, timing, and administration should be determined by a qualified healthcare professional. For international supply, appropriate prescription requirements, regulatory documentation, and cold-chain handling should also be considered.
Medical disclaimer: This article is for educational and SEO information only and does not replace advice from a qualified healthcare professional. Hepabig 100 IU Injection should be used only under appropriate medical supervision and according to the approved product information and local regulations.